Nasal cathelicidin expression in protection against Respiratory Syncytial Virus

Davidson, Donald (Principal Investigator)
Boardman, James (Co-investigator)
Bogaert, Debby (Co-investigator)
McDougall, Catherine (Co-investigator)
Schwarze, Jurgen (Co-investigator)

School of Regeneration and Repair

1 Article

1 results

Filter

2024
Nasal cathelicidin is expressed in early life and is increased during mild, but not severe Respiratory Syncytial Virus infection
Sintoris, S., Binkowska, J., Gillan, J., Zuurbier, R. P., Twynam-Perkins, J., Kristensen, M., Melrose, L., Lusarreta Parga, P., Ruiz-Rodriguez, A., Chu, M. L., Van Boeckel, S., Wildenbeest, J. G., Bowdish, D. M. E., Currie, A. J., Thwaites, R. S., Schwarze, J., van Houten, M. A., Boardman, J. P., Cunningham, S. & Bogaert, D. & 1 others, Davidson, D., 17 Jun 2024, In: Scientific Reports. 14, 1, 13928.
Research output: Contribution to journal › Article › peer-review

Open Access